A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Active Granulomatosis With Polyangiitis ...
WASHINGTON — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials ...
The FDA plans to drop its long-standing requirement that drugmakers conduct two rigorous studies to secure approval for new drugs and is also pushing to expand over-the-counter access to medications.
New free digital resource invites congregations into a sacred dialogue with Kairos Palestine II —a confession born from the heart of Palestinian Christian suffering. A Moment of Truth: Faith in a Time ...
Hwang Minhyun has been confirmed to return for Season 2 of TVING’s hit drama “Study Group”! On January 27, the production team of “Study Group” confirmed that Hwang Minhyun will reprise the lead role ...
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. When endocrinologist Mary Elizabeth Patti looks ...
William Parks is a Game Rant editor from the USA. Upon graduating from the University of Southern California’s School of Cinematic Arts, William entered the realm of fine arts administration, ...
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced that it will enroll additional patients in the ADEPT-2 study. As part of its commitment to upholding the ...
LONDON--(BUSINESS WIRE)--$SLN #SenseofSilence--Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA ...
Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...
(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) announced the presentation of new data from the Phase 2 SAVITRI study, which showed statistically significant and clinically meaningful improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results